The loss of manufacturing employment to lower cost economies has meant that countries like the UK have sought to promote innovation in areas such as biotechnology. The emergence of the ‘bioeconomy’, however, has been highly uneven, with concentrations of activity in certain countries and particular regions in those countries. In the UK, for example, there are four major concentrations of the bioeconomy. Each of these concentrations exhibit distinct patterns of knowledge and spatial inputs into the innovation process, meaning that it is important to consider the knowledge–space dynamic in and of each region.
No takes yet. Share an insight, caveat, or question.
Kean Birch (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: